DrugPipeline.net has announced the addition of “Global Antipsychotic Drugs Market 2017 - 2021” research report to their website www.DrugPipeline.net

Bangalore, India -- (SBWire) -- 07/13/2017 --Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of schizophrenic patients.

Report forecast the global antipsychotic drugs market to grow at a CAGR of 1.84% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global antipsychotic drugs market for 2017-2021. To calculate the market size, the report considers sales from both branded and generic drugs.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Antipsychotic Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- AstraZeneca
- Eli Lilly
- GlaxoSmithKline
- Johnson & Johnson

Other prominent vendors
- Actavis Generics (a subsidiary of Teva Pharmaceutical Industries)
- Alkermes
- Bristol-Myers Squibb

Market driver
- Increasing expenditure on prescription drugs
- For a full, detailed list, view our report

Market challenge
- Lack of standard diagnostic methods
- For a full, detailed list, view our report

Market trend
- Rising public interest toward mental health
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 83 pages "Global Antipsychotic Drugs Market 2017 - 2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Disease overview, Key clinical trials, Market segmentation by disease type, Market segmentation based on MoA, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-antipsychotic-drugs-market-2017-2021

Find all Healthcare Reports at - http://www.drugpipeline.net/catalog/healthcare

Related Reports;

Global Vitamin D Testing Market 2017-2021 - Visit at - http://www.drugpipeline.net/technavio/global-vitamin-d-testing-market-2017-2021

Global Safety Needles Market 2017-2021 - Visit at - http://www.drugpipeline.net/technavio/global-safety-needles-market-2017-2021

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.